Desmoplastic melanoma: an updated clinical review and the emerging role of genetic markers and immunotherapies
- PMID: 32590412
- DOI: 10.1097/CMR.0000000000000679
Desmoplastic melanoma: an updated clinical review and the emerging role of genetic markers and immunotherapies
Abstract
Desmoplastic melanoma (DM) is a rare and histopathologically as well as prognostically distinct subset of melanoma that arises in chronically sun-damaged skin. DM is typically and relatively indolent in nature with most cases not progressing to metastatic disease. DM has been managed with both radiation and surgical approaches. Medical options for the treatment of metastatic DM have traditionally been limited. Recent advances in immunotherapies have shown promising responses in DM ushering in a new class of treatment options. Additionally, with the advent of whole exome sequencing, the genetic make-up of DM has been further characterized creating new possibilities for future targeted therapies.
References
-
- Feng Z, Wu X, Chen V, Velie E, Zhang Z. Incidence and survival of desmoplastic melanoma in the United States, 1992-2007. J Cutan Pathol. 2011; 38:616–624
-
- Conley J, Lattes R, Orr W. Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma). Plastic and Reconstructive Surgery. 1972; 49:587
-
- George E, McClain SE, Slingluff CL, Polissar NL, Patterson JW. Subclassification of desmoplastic melanoma: pure and mixed variants have significantly different capacities for lymph node metastasis. J Cutan Pathol. 2009; 36:425–432
-
- Xu Z, Yibulayin F, Shi P, Feng L. Desmoplastic melanoma versus spindle cell melanoma: Incidence and survival, 1973 to 2017. Medicine (Baltimore). 2018; 97:e11563
-
- Wasif N, Gray RJ, Pockaj BA. Desmoplastic melanoma - the step-child in the melanoma family? J Surg Oncol. 2011; 103:158–162
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
